Disclaimer

VALDECOXIB 20MG-ORAL, Bextra

NOTE: April 7, 2005, Pfizer agreed to suspend sales and marketing of Bextra in the U.S., pending further discussions with the with the FDA. For more information, please read the FDA press release.

GENERIC NAME: VALDECOXIB 20MG - ORAL (val-deh-COX-ib)

BRAND NAME(S): Bextra

Warning | Medication Uses | Other Uses | How To Use | Side Effects | Precautions | Drug Interactions | Overdose | Notes | Missed Dose | Storage

WARNING: Rarely, serious (possibly fatal) allergic reactions have occurred with valdecoxib, including skin reactions. Seek immediate medical attention if an allergic reaction occurs. Symptoms of an allergic reaction may include: rash, mouth sores, itching, swelling, dizziness, trouble breathing.




Report Problems to the Food and Drug Administration

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

Pill Finder Tool

Need help identifying pills and medications?
Use the pill identifier tool on RxList.


Back to Medications Index

copyright


STAY INFORMED

Get the Latest health and medical information delivered direct to your inbox!